Main
About Resourse
Suggestions and comments
Select language:
Name of the term
БЕЛ
БЯСПЕКА ЛЕКАВАГА СРОДКУ
РУС
БЕЗОПАСНОСТЬ ЛЕКАРСТВЕННОГО СРЕДСТВА
ENG
SAFETY OF MEDICINE
Associative links
-
OVERDOSE
-
MEDICATION ERROR
-
ENTANGLEMENT
-
QUALITY ASSURANCE PROGRAMME
-
ABUSE OF A MEDICINAL PRODUCTS
-
MISSING INFORMATION
-
REFERENCE SAFETY INFORMATION
-
SAFETY
-
MEDICATIONS
-
COMPANY СORE DATA SHEET (CCDS)
-
SIGNIFICANT CHANGE OF II TYPE
-
SIDE EFFECT
-
POOR-QUALITY MEDICINAL PRODUCT
-
BIOLOGICAL AVAILABILITY (BIOAVAILABILITY)
-
DOSE MEDICINE
-
INDIVIDUAL CASE SAFETY REPORT (ICSR) (ADVERSE (DRUG) REACTION REPORT)
-
BIOANOLOGICAL MEDICINE (BIOANALOGUE, BIO-LIKE MEDICINE, BIOSIMILAR)
-
HYBRID MEDICINE
-
BIOLOGICAL MEDICINES
-
BIOWAIVER
-
BIOLOGICAL ACTIVITY
-
INVESTIGATIONAL MEDICINAL PRODUCT
-
IMPORTANT MISSING INFORMATION
-
SPECIFICATION ON TEST ITEM
-
IMPORTANT IDENTIFIED RISK AND IMPORTANT POTENTIAL RISK
-
PERIODIC SAFETY UPDATE REPORT (PSUR)
-
ASEPTIC CONDITIONS
-
INVESTIGATIONAL SUBSTANCE (MEDICINAL PRODUCT)
-
REAL TIME TESTS
-
BALK PRODUCTS
-
BIOAVAILABILITY
-
STRENGTH MEDICINE
-
SECURITY OF THE MEDICINE (RISK-BENEFIT BALANCE)
-
BIOLOGICAL EQUIVALENCE (BIOEQUIVALENCE)
-
REFERENCE ITEM (CONTROL ITEM)
-
INSTRUCTION FOR MEDICAL USE (LEAFLET)
-
POLICY IN THE FIELD OF PHARMACEUTICAL INSPECTORATE QUALITY
-
INVESTIGATIONAL DRUG
-
SAFETY OF MEDICINES
-
BIOEQUIVALENCE
-
SPECIMEN (SUPPLEMENTS)
-
PROPER PHARMACOLOGICAL CONTROL PRACTICE
-
DEVELOPMENT SAFETY UPDATE REPORT (DSUR)
-
ADULTERATED MEDICAL DRUG
-
BIOANOLOGICAL MEDICINE, BIOANALOGUE, BIO-LIKE MEDICINE, BIOSIMILAR
-
BIOLOGICAL MEDICINE
Back to search
Report a mistake